MORGAN STANLEY - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 15 filers reported holding EYEGATE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,000
-50.0%
4660.0%0.00%
Q2 2021$2,0000.0%4660.0%0.00%
Q1 2021$2,0000.0%4660.0%0.00%
Q4 2020$2,0000.0%4660.0%0.00%
Q3 2020$2,0000.0%4660.0%0.00%
Q2 2020$2,0000.0%4660.0%0.00%
Q1 2020$2,000
-33.3%
466
+39.9%
0.00%
Q4 2019$3,000
+200.0%
333
-2.6%
0.00%
Q3 2019$1,0003420.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,815,500$8,950,0000.30%
Sterling Financial Planning, Inc. 1,171$6,0000.01%
UBS Group AG 3,991$20,0000.00%
OSAIC HOLDINGS, INC. 468$2,0000.00%
US BANCORP \DE\ 2,710$13,0000.00%
WELLS FARGO & COMPANY/MN 34$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 12,656$62,0000.00%
North Star Investment Management Corp. 20$00.00%
MORGAN STANLEY 466$2,0000.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders